Academia-Industry collaborations can enhance innovation, leading to various benefits for:

  • Society: fast-track development of practical applications (e.g. new improved medical devices, techniques and therapies), launch of start-ups, novel job opportunities, increased competitive advantage of a region/country…
  • Academy: financial return of investment resulting from commercialisation of academic research (e.g. patent and licenses), access to cutting-edge scientific equipment, enhancing institutional prestige…
  • Industry: competitive advantage as the prior academic cutting-edge research decreases the time (and risk) it takes to bring a product from the lab to the market, enhancement of a company’s reputation, strengthening of the company’s own research and development…

The collaboration between academic researchers, (start-up) companies and industry funding is, however, complex. At the IVU, we can help you with:

  • Promoting your innovative, application-oriented developments
  • Bringing your technology to the market (e.g. licensing, spin-off)
  • Building a strategic commercial (patent) portfolio
  • Setting-up collaborations between university and industry
  • Negotiations on IP, return of investment…

Advanced Cell and Tissue Engineering (ACT-T)

The Advanced Cell and Tissue Engineering (ACT-T) consortium is led by business developer Tim Desmet and focuses on cell therapies and tissue engineering. It is part of the IOF Industrial Liaison Network, a framework for collaboration between the Ghent University Association and industry (link).  

ACT-T covers the entire trajectory from fundamental research up to, and including, first-in-human for both cell therapies and tissue engineering. Clinical proof-of-concept is herein essential.

The consortium provides support in:

  • Identifying valorisation opportunities
  • Setting-up industrial collaborations
  • Expanding the cell- and tissue therapy network
  • Maximizing the economic and societal impact

The research topics which are ongoing and supported by ACT-T are shown in the figure below